Evaluation of glycine treatment for reducing alcohol craving and self‐administration in individuals with alcohol use disorder: A human laboratory trial

Documents similaires

• Variations in alcohol craving and negative mood during a clinical trial of ibudilast for alcohol use disorder
  par: Lindsay R. Meredith, et autres
  Publié: (2025)
• Neuroimmune pathways as targets for precision treatment in alcohol use disorder: A commentary on biomarkers for craving
  par: Lewis Nunez Severino, et autres
  Publié: (2026)
• The effect of alcohol withdrawal therapy on gut microbiota in alcohol use disorder and its link to inflammation and craving
  par: Phileas J. Proskynitopoulos, et autres
  Publié: (2025)
• Effects of prazosin treatment on liver enzymes are moderated by alcohol withdrawal symptoms in individuals with alcohol use disorder
  par: Bradford S. Martins, et autres
  Publié: (2024)
• Physical sensations of craving in binge drinking and severe alcohol use disorder: A phenomenological approach
  par: Pauline Billaux, et autres
  Publié: (2025)